Literature DB >> 23152158

Clinical manifestations associated with Kawasaki disease shock syndrome in Mexican children.

Luisa Berenise Gámez-González1, Chiharu Murata, Mireya Muñoz-Ramírez, Marco Yamazaki-Nakashimada.   

Abstract

UNLABELLED: Recently, there have been increasing reports of severe forms of Kawasaki disease (KD) associated with shock that have been managed in pediatric intensive care units. It has been suggested that KD is more severe in the Hispanic population. We conducted a study to determine the frequency of Kawasaki disease shock syndrome (KDSS) in our population and compared characteristics between patients with KD without shock and patients with KDSS. Data from 214 patients with KD treated in a tertiary pediatric hospital were collected during a 12-year period. We compared clinical and laboratory features of KD patients without shock and KDSS patients. Of 214 consecutive patients with KD, 11 (5 %) met the definition for KDSS. All of these patients received fluid resuscitation, seven (64 %) required inotropic treatment, and six (54 %), ventilatory support. On admission, seven of these patients (64 %) had an incomplete presentation of the disease, whereas in the group of patients without shock, the relative frequency of an incomplete presentation was 29 %. Twenty percent (3/11) of patients with KDSS presented giant coronary aneurysms versus none of 203 KD patients without shock (p = 0.001); myocardial infarction, 27 % (3/11), versus 1 % (2/203) (p = 0.001); and intravenous immunoglobulin (IVIG) resistance, 60 % (6/11), versus 12 % (24/203). Gastrointestinal manifestations in the acute phase occurred in 91 % of KDSS patients versus 30 % patients without shock (p = 0.001).
CONCLUSION: Patients with KD presenting in shock seem to have an increase in gastrointestinal manifestations, incomplete presentation, IVIG resistance, and worse cardiac outcomes. Larger, prospective, multicentre studies should be carried out to corroborate these findings.

Entities:  

Mesh:

Year:  2012        PMID: 23152158     DOI: 10.1007/s00431-012-1879-1

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  19 in total

1.  Kawasaki disease: an unexpected etiology of shock and multiple organ dysfunction syndrome.

Authors:  Pauline Gatterre; Mehdi Oualha; Laurent Dupic; Franck Iserin; Christine Bodemer; Fabrice Lesage; Philippe Hubert
Journal:  Intensive Care Med       Date:  2012-01-25       Impact factor: 17.440

2.  Kawasaki disease complicated by cutaneous vasculitis and peripheral gangrene.

Authors:  Elisabeth Gomez-Moyano; Angel Vera Casaño; Jose Camacho; Andres Sanz Trelles; Vicente Crespo-Erchiga
Journal:  J Am Acad Dermatol       Date:  2011-05       Impact factor: 11.527

3.  Shock: an unusual presentation of Kawasaki disease.

Authors:  Farah Thabet; Hend Bafaqih; Suleiman Al-Mohaimeed; Mariam Al-Hilali; Wafaa Al-Sewairi; May Chehab
Journal:  Eur J Pediatr       Date:  2011-02-24       Impact factor: 3.183

Review 4.  Simultaneous presentation of Kawasaki disease and toxic shock syndrome in an adolescent male.

Authors:  H D Davies; V Kirk; T Jadavji; B L Kotzin
Journal:  Pediatr Infect Dis J       Date:  1996-12       Impact factor: 2.129

5.  Cardiogenic shock: do not forget the possibility of Kawasaki disease.

Authors:  Wei Wang; Wei-Hua Zhu; Yan-Qi Qi; Song-Ling Fu; Fang-Qi Gong
Journal:  Turk J Pediatr       Date:  2012 Jan-Feb       Impact factor: 0.552

6.  Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome.

Authors:  H Kato; S Koike; M Yamamoto; Y Ito; E Yano
Journal:  J Pediatr       Date:  1975-06       Impact factor: 4.406

7.  [Streptococcal toxic shock syndrome or Kawasaki disease? Two case studies of children with group A streptococcal pneumonia empyema].

Authors:  A Bosland; K Arlaud; C Rousset-Rouvière; V Fouilloux; O Paut; J-C Dubus; E Bosdure
Journal:  Arch Pediatr       Date:  2011-10-29       Impact factor: 1.180

8.  Rate, associated factors and outcomes of recurrence of Kawasaki disease in Ontario, Canada.

Authors:  Nita Chahal; Zeeshanefatema Somji; Cedric Manlhiot; Nadia A Clarizia; Justin Ashley; Rae S M Yeung; Brian W McCrindle
Journal:  Pediatr Int       Date:  2012-06       Impact factor: 1.524

9.  Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease.

Authors:  Jane W Newburger; Lynn A Sleeper; Brian W McCrindle; L LuAnn Minich; Welton Gersony; Victoria L Vetter; Andrew M Atz; Jennifer S Li; Masato Takahashi; Annette L Baker; Steven D Colan; Paul D Mitchell; Gloria L Klein; Robert P Sundel
Journal:  N Engl J Med       Date:  2007-02-15       Impact factor: 91.245

Review 10.  The role of superantigens of group A Streptococcus and Staphylococcus aureus in Kawasaki disease.

Authors:  Kousaku Matsubara; Takashi Fukaya
Journal:  Curr Opin Infect Dis       Date:  2007-06       Impact factor: 4.915

View more
  19 in total

Review 1.  Kawasaki shock syndrome in an Arab female: case report of a rare manifestation and review of literature.

Authors:  Ahmed A Nugud; Assmaa Nugud; Deena Wafadari; Walid Abuhammour
Journal:  BMC Pediatr       Date:  2019-08-23       Impact factor: 2.125

2.  Acute Abdomen in Kawasaki Disease.

Authors:  Natalia Velez-Tirado; Cecilia Ridaura-Sanz; Edna Venegas-Montoya; Selma Scheffler-Mendoza; Rosalinda Camacho-Moreno; Francisco Otero-Mendoza; Francisco Antonio Medina-Vega; Luis Martín Garrido-García; Francisco Rivas-Larrauri; Marco Antonio Yamazaki Nakashimada
Journal:  Indian J Pediatr       Date:  2019-08-07       Impact factor: 1.967

Review 3.  Describing Kawasaki shock syndrome: results from a retrospective study and literature review.

Authors:  Andrea Taddio; Eleonora Dei Rossi; Lorenzo Monasta; Serena Pastore; Alberto Tommasini; Loredana Lepore; Gabriele Bronzetti; Edoardo Marrani; Biancamaria D'Agata Mottolese; Gabriele Simonini; Rolando Cimaz; Alessandro Ventura
Journal:  Clin Rheumatol       Date:  2016-05-26       Impact factor: 2.980

4.  Kawasaki disease shock syndrome: A report of two cases and literature review.

Authors:  Qingyou Zhang; Ying Liao; Junbao Du
Journal:  Pediatr Investig       Date:  2019-06-25

Review 5.  The Complexities of the Diagnosis and Management of Kawasaki Disease.

Authors:  Anne H Rowley
Journal:  Infect Dis Clin North Am       Date:  2015-07-04       Impact factor: 5.982

6.  Clinical Analysis of Kawasaki Disease Shock Syndrome.

Authors:  Ming-Ming Zhang; Lin Shi; Xiao-Hui Li; Yao Lin; Yang Liu
Journal:  Chin Med J (Engl)       Date:  2017-12-05       Impact factor: 2.628

7.  Capillary leak syndrome and aseptic meningitis in a patient with Kawasaki disease: A case report.

Authors:  Yufeng Zhang; Han Wan; Maosheng Du; Huiling Deng; Jia Fu; Yu Zhang; Xiaoyan Wang; Ruiqing Liu
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

8.  [Atypical and incomplete Kawasaki disease in pediatric age].

Authors:  Norberto Sotelo-Cruz
Journal:  Bol Med Hosp Infant Mex       Date:  2016-05-31

9.  Kawasaki disease shock syndrome complicated with macrophage activation syndrome in a 5-month old boy: A case report.

Authors:  Yao Lin; Lin Shi; Yan-Jun Deng; Yang Liu; Hong-Wei Zhang
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

Review 10.  The Clinical Diagnosis and Management of Kawasaki Disease: a Review and Update.

Authors:  Frank H Zhu; Jocelyn Y Ang
Journal:  Curr Infect Dis Rep       Date:  2016-09       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.